The urokinase plasminogen activator system as a novel target for tumour therapy

This publication has 139 references indexed in Scilit:

• Cellular Distribution and Clinical Value of Urokinase-Type Plasminogen Activator, Its Receptor, and Plasminogen Activator Inhibitor-2 in Esophageal Squamous Cell Carcinoma
  The American Journal of Pathology, 2000
• Reduction of tumor cell migration and metastasis by adenoviral gene transfer of plasminogen activator inhibitors
  Gene Therapy, 1999
• Binding of Urokinase-type Plasminogen Activator to Its Receptor in MCF-7 Cells Activates Extracellular Signal-regulated Kinase 1 and 2 Which Is Required for Increased Cellular Motility
  Published by Elsevier ,1998
• Requirement of Receptor-bound Urokinase-type Plasminogen Activator for Integrin αvβ5-directed Cell Migration
  Journal of Biological Chemistry, 1996
• Urokinase plasminogen activator, a strong independent prognostic factor in breast cancer, analysed in steroid receptor cytosols with a luminometric immunoassay
  European Journal Of Cancer, 1996
• Blockage of the urokinase receptor on the cell surface: Construction and characterization of a hybrid protein consisting of the N‐terminal fragment of human urokinase and human albumin
  FEBS Letters, 1994
• Recombinant soluble urokinase receptor as a scavenger for urokinase‐type plasminogen activator (uPA)
  FEBS Letters, 1994
• An amino-terminal fragment of urokinase isolated from a prostate cancer cell line (PC-3) is mitogenic for osteoblast-like cells
  Biochemical and Biophysical Research Communications, 1990
• UROKINASE-TYPE PLASMINOGEN ACTIVATOR ANTIGEN AND EARLY RELAPSE IN BREAST CANCER
  The Lancet, 1989
• Human urokinase-type plasminogen activator stimulates chemotaxis of human neutrophils
  Biochemical and Biophysical Research Communications, 1987